We are live on ! Find out more
CGL

Column Group LP Portfolio holdings

AUM $38.6M
1-Year Est. Return 30.92%
This Fund
S&P 500
This Quarter Est. Return
+74.29%
1 Year Est. Return
-30.92%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$97.1M
AUM Growth
–
Cap. Flow
+$87.9M
Cap. Flow %
90.54%
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
IMDZ
Immune Design Corp.
IMDZ
+$87.9M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMDZ
1
DELISTED
Immune Design Corp.
IMDZ
$97.1M 100%
+3,161,942
New +$87.9M

Similar funds

RCI
RRJ Capital II Grand Cayman, Cayman Islands $38.8M AUM 0.84% 1-Year Est. Return
RCM
Royal Capital Management New York $37.2M AUM 3.86% 1-Year Est. Return
TIM
TBP Investments Management Dallas, Texas $37.1M AUM 30.88% 1-Year Est. Return
SGC
South Georgia Capital Naperville, Illinois $41M AUM 2.47% 1-Year Est. Return
BC
Balestra Capital New York $42.5M AUM
AIC
Atlantic Investment Company Atlanta, Georgia $34.3M AUM 10.7% 1-Year Est. Return
ACMM
American Capital Mortgage Management Bethesda, Maryland $33.9M AUM 13.41% 1-Year Est. Return
OCM
Orrell Capital Management Livermore, California $43.6M AUM 28.35% 1-Year Est. Return

Column Group LP's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Column Group LP, which disclosed 1 position worth $97.1M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Immune Design Corp.: 3,161,942 shares worth $97.1M.

  • Column Group LP's largest Q4 2014 buy was Immune Design Corp.: 3,161,942 shares worth $97.1M.
  • Column Group LP's ten largest holdings make up 100% of its $97.1M portfolio in Q4 2014.
  • Column Group LP disclosed 1 position in Q4 2014, its first 13F filing on record.

Based on Column Group LP's 13F filing for Q4 2014, filed 5 Feb 2015.